Kabra Drugs Ltd — Board Meeting, 13-11-2025: Board Meeting
13-11-2025 | 06:55 pm
13-11-2025 | 06:55 pm
Kabra Drugs' Board approved Q2 & H1 financial results. Q2 Net Profit stood at ₹1.84 Cr, and H1 Net Profit at ₹1.34 Cr. The Board also reconstituted its composition and committees. #KabraDrugs #Earnings
No comments yet. Be the first to comment!
